4D Molecular Therapeutics IncNASDAQ:FDMT
- LAST PRICE21.4800
- TODAY'S CHANGE (%)0.4300 (2.0428%)
- Bid / Lots21.3000/ 2
- Ask / Lots23.1200/ 2
- Open / Previous Close21.0500 / 21.0500
- Day Range
- 52 Week Range
- Volume333,685
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FDMT |
|---|---|---|
| 09:32 ET | 1864 | 21.545 |
| 09:33 ET | 3294 | 20.92 |
| 09:35 ET | 1000 | 20.7 |
| 09:37 ET | 1870 | 20.5 |
| 09:39 ET | 1868 | 20.78 |
| 09:44 ET | 100 | 20.77 |
| 09:46 ET | 100 | 20.89 |
| 09:48 ET | 400 | 20.99 |
| 09:50 ET | 300 | 21.045 |
| 09:51 ET | 505 | 21.12 |
| 09:53 ET | 200 | 21.16 |
| 09:55 ET | 380 | 21.055 |
| 09:57 ET | 200 | 21.18 |
| 10:00 ET | 1300 | 21.2 |
| 10:02 ET | 1305 | 21.08 |
| 10:06 ET | 13982 | 21.11 |
| 10:08 ET | 172 | 21.165 |
| 10:09 ET | 100 | 21.265 |
| 10:11 ET | 1865 | 21.1 |
| 10:13 ET | 2400 | 21.14 |
| 10:18 ET | 2904 | 21.14 |
| 10:20 ET | 200 | 21.12 |
| 10:26 ET | 700 | 21.16 |
| 10:27 ET | 100 | 21.16 |
| 10:29 ET | 501 | 21.095 |
| 10:31 ET | 3143 | 21.1 |
| 10:33 ET | 2983 | 21.179 |
| 10:36 ET | 100 | 21.175 |
| 10:38 ET | 100 | 21.27 |
| 10:40 ET | 200 | 21.2 |
| 10:42 ET | 200 | 21.21 |
| 10:44 ET | 610 | 21.2 |
| 10:45 ET | 156 | 21.13 |
| 10:47 ET | 1168 | 21.18 |
| 10:49 ET | 100 | 21.26 |
| 10:51 ET | 100 | 21.28 |
| 10:54 ET | 2803 | 21.22 |
| 10:56 ET | 3100 | 21.145 |
| 10:58 ET | 400 | 21.08 |
| 11:02 ET | 200 | 21.07 |
| 11:09 ET | 300 | 21.08 |
| 11:12 ET | 600 | 21.115 |
| 11:14 ET | 300 | 21.08 |
| 11:16 ET | 100 | 21.15 |
| 11:20 ET | 100 | 21.15 |
| 11:21 ET | 300 | 21.08 |
| 11:23 ET | 1500 | 21.05 |
| 11:27 ET | 100 | 21.03 |
| 11:36 ET | 300 | 20.99 |
| 11:38 ET | 200 | 20.99 |
| 11:39 ET | 817 | 21.06 |
| 11:41 ET | 600 | 21.06 |
| 11:43 ET | 1000 | 21.12 |
| 11:45 ET | 4100 | 21.095 |
| 11:48 ET | 500 | 21.09 |
| 11:50 ET | 100 | 21.13 |
| 11:52 ET | 200 | 21.09 |
| 11:56 ET | 100 | 21.09 |
| 11:57 ET | 200 | 21.08 |
| 11:59 ET | 100 | 21.16 |
| 12:01 ET | 3008 | 21.05 |
| 12:03 ET | 100 | 21.0699 |
| 12:06 ET | 305 | 21.05 |
| 12:08 ET | 500 | 21.08 |
| 12:12 ET | 200 | 21.095 |
| 12:14 ET | 300 | 21.04 |
| 12:15 ET | 364 | 21 |
| 12:17 ET | 200 | 21.06 |
| 12:19 ET | 521 | 21.08 |
| 12:21 ET | 100 | 21.05 |
| 12:24 ET | 700 | 21.03 |
| 12:26 ET | 100 | 21.05 |
| 12:30 ET | 2200 | 21.04 |
| 12:33 ET | 500 | 21.02 |
| 12:35 ET | 300 | 21.03 |
| 12:39 ET | 100 | 21.07 |
| 12:42 ET | 100 | 21.055 |
| 12:46 ET | 400 | 21.06 |
| 12:48 ET | 200 | 21.03 |
| 12:51 ET | 400 | 21.06 |
| 12:53 ET | 100 | 21.05 |
| 12:55 ET | 800 | 21.1 |
| 12:57 ET | 978 | 21.08 |
| 01:00 ET | 600 | 21.05 |
| 01:02 ET | 700 | 21.11 |
| 01:04 ET | 3000 | 21.22 |
| 01:06 ET | 978 | 21.225 |
| 01:08 ET | 720 | 21.21 |
| 01:09 ET | 2617 | 21.2 |
| 01:11 ET | 200 | 21.19 |
| 01:13 ET | 500 | 21.19 |
| 01:15 ET | 200 | 21.21 |
| 01:18 ET | 804 | 21.17 |
| 01:20 ET | 200 | 21.165 |
| 01:22 ET | 2575 | 21.125 |
| 01:24 ET | 100 | 21.1 |
| 01:26 ET | 1491 | 21.2363 |
| 01:27 ET | 4662 | 21.15 |
| 01:29 ET | 200 | 21.06 |
| 01:33 ET | 200 | 21.07 |
| 01:36 ET | 100 | 21.1 |
| 01:38 ET | 384 | 21.115 |
| 01:40 ET | 100 | 21.18 |
| 01:42 ET | 1902 | 21.14 |
| 01:44 ET | 100 | 21.09 |
| 01:45 ET | 1600 | 21.15 |
| 01:47 ET | 2300 | 21.15 |
| 01:51 ET | 500 | 21.08 |
| 01:54 ET | 300 | 21.04 |
| 01:56 ET | 500 | 20.99 |
| 01:58 ET | 200 | 20.99 |
| 02:00 ET | 100 | 21.12 |
| 02:02 ET | 2256 | 21.105 |
| 02:03 ET | 100 | 21.06 |
| 02:05 ET | 3744 | 21.15 |
| 02:07 ET | 3592 | 21.3 |
| 02:09 ET | 1800 | 21.405 |
| 02:12 ET | 1554 | 21.53 |
| 02:14 ET | 500 | 21.58 |
| 02:16 ET | 1100 | 21.67 |
| 02:18 ET | 3215 | 21.44 |
| 02:20 ET | 900 | 21.51 |
| 02:25 ET | 1700 | 21.43 |
| 02:30 ET | 2328 | 21.43 |
| 02:32 ET | 3137 | 21.2401 |
| 02:36 ET | 100 | 21.225 |
| 02:38 ET | 1025 | 21.34 |
| 02:39 ET | 1100 | 21.485 |
| 02:41 ET | 1400 | 21.695 |
| 02:43 ET | 2179 | 21.68 |
| 02:45 ET | 630 | 21.75 |
| 02:48 ET | 1100 | 21.795 |
| 02:50 ET | 300 | 21.85 |
| 02:52 ET | 1390 | 21.78 |
| 02:54 ET | 2874 | 21.73 |
| 02:57 ET | 200 | 21.715 |
| 02:59 ET | 600 | 21.655 |
| 03:01 ET | 300 | 21.68 |
| 03:03 ET | 200 | 21.74 |
| 03:06 ET | 1385 | 21.875 |
| 03:08 ET | 2461 | 21.84 |
| 03:10 ET | 1000 | 21.86 |
| 03:12 ET | 2000 | 21.835 |
| 03:14 ET | 500 | 21.785 |
| 03:17 ET | 700 | 21.655 |
| 03:19 ET | 1900 | 21.71 |
| 03:21 ET | 500 | 21.78 |
| 03:24 ET | 411 | 21.74 |
| 03:26 ET | 700 | 21.75 |
| 03:28 ET | 2113 | 21.675 |
| 03:30 ET | 1300 | 21.68 |
| 03:32 ET | 600 | 21.68 |
| 03:33 ET | 1806 | 21.65 |
| 03:35 ET | 1200 | 21.685 |
| 03:37 ET | 2000 | 21.77 |
| 03:39 ET | 1121 | 21.71 |
| 03:42 ET | 1400 | 21.74 |
| 03:44 ET | 2961 | 21.7525 |
| 03:46 ET | 2100 | 21.69 |
| 03:48 ET | 200 | 21.65 |
| 03:50 ET | 2383 | 21.565 |
| 03:51 ET | 5316 | 21.525 |
| 03:53 ET | 3149 | 21.49 |
| 03:55 ET | 3399 | 21.55 |
| 03:57 ET | 2594 | 21.57 |
| 04:00 ET | 46791 | 21.48 |
Jan 30, 2023
BMO Capital Starts 4D Molecular Therapeutics at Outperform With $50 Price Target, from 7:04AM ET on Monday Jan 30, 2023 by MT Newswires
7:04AM ET on Monday Jan 30, 2023 by MT Newswires
Jan 9, 2023
BRIEF-4D Molecular Therapeutics Announces Updates On Clinical Pipeline And Additional Preclinical Programs, from 9:06AM ET on Monday Jan 09, 2023 by Thomson Reuters
9:06AM ET on Monday Jan 09, 2023 by Thomson Reuters4D Molecular Therapeutics Announces Updates on Clinical Pipeline and Additional Preclinical Programs, from 9:00AM ET on Monday Jan 09, 2023 by GlobeNewswire
9:00AM ET on Monday Jan 09, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
4D Molecular Therapeutics Inc | 681.9M | -6.5x | --- |
Editas Medicine Inc | 680.1M | -3.5x | --- |
Scholar Rock Holding Corp | 625.1M | -4.4x | --- |
Altimmune Inc | 670.5M | -7.2x | --- |
Protagonist Therapeutics Inc | 653.8M | -5.3x | --- |
Cara Therapeutics Inc | 627.6M | -7.1x | --- |
Company Information
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company. The Company is focused on creating and developing targeted and evolved adeno-associated viruses (AAV) vectors. The Company’s product candidates are focused various areas, including ophthalmology, cardiology, and pulmonology. The Company's product candidates include 4D-125, 4D-150, 4D-110, 4D-310, and 4D-710. 4D-125 for the treatment of patients with X-Linked Retinitis Pigmentosa (XLRP) with retinitis pigmentosa GTPase regulator (RPGR) gene. 4D-150 is developed for the treatment of wet age-related macular degeneration (wet-AMD). 4D-110 is developed for the treatment of choroideremia. 4D-310 is developed for the systemic treatment of Fabry disease. The Company is developing 4D-710 for the treatment of a broad range of patients with cystic fibrosis independent of their cystic fibrosis transmembrane conductance regulator (CFTR).
Contact Information
- Headquarters
- 5858 Horton Street #455, EmeryvilleEMERYVILLE, CA, United States 94608
- Phone
- 510-505-2680
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- John Milligan
- President, Chief Operating Officer
- Fred Kamal
- Chief Executive Officer, Co-Founder, Director
- David Kirn
- Chief Financial Officer
- August Moretti
- Chief Medical Officer
- Robert Fishman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $681.9M |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 32.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.30 |
Book Value | $9.90 |
P/E Ratio | -6.5x |
Price/Sales (TTM) | 345.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5,376.43% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
